Express Learning Breakout
Despite the complex treatment Oncology and Haematology patients require, and the frequent use of Central Venous Access Devices, the use of Peripheral Intravenous catheters (PIV) remains common. Specific risk factors contributing to PIV failure among Cancer Care patients are under-reported. Two hundred patients requiring a PIV upon admission to an Oncology or Haematology unit of a tertiary hospital were prospectively followed from admission through to discharge. Each PIV the patient received throughout this time was followed and documented to understand how risk factors, both modifiable (eg. PIV location) and non-modifiable (eg. gender), impacted upon the primary outcome - PIV failure. Furthermore, patients were interviewed about their PIV to understand the emotional and physical impact of PIV failure; and inform future research.